Molecular characterization and reclassification of a 1.18 Mbp DMD duplication following positive carrier screening for Duchenne/Becker muscular dystrophy

Abstract A 2‐month‐old male patient harboring a duplication of DMD exons 1–7 classified as pathogenic by an outside institution presented with mildly elevated creatine phosphokinase (CK); molecular breakpoint analysis by our laboratory reclassified the duplication as likely benign. To date, proband...

Full description

Bibliographic Details
Main Authors: Cinthya J. Zepeda‐Mendoza, Jordan E. Bontrager, Camille F. Fisher, Amber McDonald, Jaya K. George‐Abraham, Linda Hasadsri
Format: Article
Language:English
Published: Wiley 2022-07-01
Series:Clinical Case Reports
Subjects:
Online Access:https://doi.org/10.1002/ccr3.6008
_version_ 1811222700089147392
author Cinthya J. Zepeda‐Mendoza
Jordan E. Bontrager
Camille F. Fisher
Amber McDonald
Jaya K. George‐Abraham
Linda Hasadsri
author_facet Cinthya J. Zepeda‐Mendoza
Jordan E. Bontrager
Camille F. Fisher
Amber McDonald
Jaya K. George‐Abraham
Linda Hasadsri
author_sort Cinthya J. Zepeda‐Mendoza
collection DOAJ
description Abstract A 2‐month‐old male patient harboring a duplication of DMD exons 1–7 classified as pathogenic by an outside institution presented with mildly elevated creatine phosphokinase (CK); molecular breakpoint analysis by our laboratory reclassified the duplication as likely benign. To date, proband continues to develop normally with decreased CK, further supporting our reclassification.
first_indexed 2024-04-12T08:19:32Z
format Article
id doaj.art-1270659793a3440bacd9b40755d7de07
institution Directory Open Access Journal
issn 2050-0904
language English
last_indexed 2024-04-12T08:19:32Z
publishDate 2022-07-01
publisher Wiley
record_format Article
series Clinical Case Reports
spelling doaj.art-1270659793a3440bacd9b40755d7de072022-12-22T03:40:38ZengWileyClinical Case Reports2050-09042022-07-01107n/an/a10.1002/ccr3.6008Molecular characterization and reclassification of a 1.18 Mbp DMD duplication following positive carrier screening for Duchenne/Becker muscular dystrophyCinthya J. Zepeda‐Mendoza0Jordan E. Bontrager1Camille F. Fisher2Amber McDonald3Jaya K. George‐Abraham4Linda Hasadsri5Division of Laboratory Genetics and Genomics Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota USADivision of Laboratory Genetics and Genomics Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota USADell Children's Medical Group Austin Texas USADivision of Laboratory Genetics and Genomics Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota USADell Children's Medical Group Austin Texas USADivision of Laboratory Genetics and Genomics Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota USAAbstract A 2‐month‐old male patient harboring a duplication of DMD exons 1–7 classified as pathogenic by an outside institution presented with mildly elevated creatine phosphokinase (CK); molecular breakpoint analysis by our laboratory reclassified the duplication as likely benign. To date, proband continues to develop normally with decreased CK, further supporting our reclassification.https://doi.org/10.1002/ccr3.6008DMDDuchenne muscular dystrophyduplicationdystrophinopathy
spellingShingle Cinthya J. Zepeda‐Mendoza
Jordan E. Bontrager
Camille F. Fisher
Amber McDonald
Jaya K. George‐Abraham
Linda Hasadsri
Molecular characterization and reclassification of a 1.18 Mbp DMD duplication following positive carrier screening for Duchenne/Becker muscular dystrophy
Clinical Case Reports
DMD
Duchenne muscular dystrophy
duplication
dystrophinopathy
title Molecular characterization and reclassification of a 1.18 Mbp DMD duplication following positive carrier screening for Duchenne/Becker muscular dystrophy
title_full Molecular characterization and reclassification of a 1.18 Mbp DMD duplication following positive carrier screening for Duchenne/Becker muscular dystrophy
title_fullStr Molecular characterization and reclassification of a 1.18 Mbp DMD duplication following positive carrier screening for Duchenne/Becker muscular dystrophy
title_full_unstemmed Molecular characterization and reclassification of a 1.18 Mbp DMD duplication following positive carrier screening for Duchenne/Becker muscular dystrophy
title_short Molecular characterization and reclassification of a 1.18 Mbp DMD duplication following positive carrier screening for Duchenne/Becker muscular dystrophy
title_sort molecular characterization and reclassification of a 1 18 mbp dmd duplication following positive carrier screening for duchenne becker muscular dystrophy
topic DMD
Duchenne muscular dystrophy
duplication
dystrophinopathy
url https://doi.org/10.1002/ccr3.6008
work_keys_str_mv AT cinthyajzepedamendoza molecularcharacterizationandreclassificationofa118mbpdmdduplicationfollowingpositivecarrierscreeningforduchennebeckermusculardystrophy
AT jordanebontrager molecularcharacterizationandreclassificationofa118mbpdmdduplicationfollowingpositivecarrierscreeningforduchennebeckermusculardystrophy
AT camilleffisher molecularcharacterizationandreclassificationofa118mbpdmdduplicationfollowingpositivecarrierscreeningforduchennebeckermusculardystrophy
AT ambermcdonald molecularcharacterizationandreclassificationofa118mbpdmdduplicationfollowingpositivecarrierscreeningforduchennebeckermusculardystrophy
AT jayakgeorgeabraham molecularcharacterizationandreclassificationofa118mbpdmdduplicationfollowingpositivecarrierscreeningforduchennebeckermusculardystrophy
AT lindahasadsri molecularcharacterizationandreclassificationofa118mbpdmdduplicationfollowingpositivecarrierscreeningforduchennebeckermusculardystrophy